HEADER HORMONE/GROWTH FACTOR 08-JUN-01 1JCA TITLE NON-STANDARD DESIGN OF UNSTABLE INSULIN ANALOGUES WITH ENHANCED TITLE 2 ACTIVITY COMPND MOL_ID: 1; COMPND 2 MOLECULE: INSULIN A; COMPND 3 CHAIN: A, C; COMPND 4 ENGINEERED: YES; COMPND 5 MUTATION: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: INSULIN B; COMPND 8 CHAIN: B, D; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: THIS PEPTIDE WAS CHEMICALLY SYNTHESIZED. THE SEQUENCE SOURCE 4 OF THE PEPTIDE IS NATURALLY FOUND IN HOMO SAPIENS (HUMANS).; SOURCE 5 MOL_ID: 2; SOURCE 6 SYNTHETIC: YES; SOURCE 7 OTHER_DETAILS: THIS PEPTIDE WAS CHEMICALLY SYNTHESIZED. THE SEQUENCE SOURCE 8 OF THE PEPTIDE IS NATURALLY FOUND IN HOMO SAPIENS (HUMANS). KEYWDS A8-LYSINE HUMAN INSULIN, INSULIN RECEPTOR, HORMONE-GROWTH FACTOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.A.WEISS,Z.WAN,M.ZHAO,Y.-C.CHU,S.H.NAKAGAWA,G.T.BURKE,W.JIA, AUTHOR 2 R.HELLMICH,P.G.KATSOYANNIS REVDAT 7 16-AUG-23 1JCA 1 REMARK REVDAT 6 27-OCT-21 1JCA 1 REMARK SEQADV LINK REVDAT 5 13-JUL-11 1JCA 1 VERSN REVDAT 4 24-FEB-09 1JCA 1 VERSN REVDAT 3 01-APR-03 1JCA 1 JRNL REVDAT 2 16-JAN-02 1JCA 1 AUTHOR JRNL REVDAT 1 20-JUN-01 1JCA 0 JRNL AUTH M.A.WEISS,Z.WAN,M.ZHAO,Y.C.CHU,S.H.NAKAGAWA,G.T.BURKE,W.JIA, JRNL AUTH 2 R.HELLMICH,P.G.KATSOYANNIS JRNL TITL NON-STANDARD INSULIN DESIGN: STRUCTURE-ACTIVITY JRNL TITL 2 RELATIONSHIPS AT THE PERIPHERY OF THE INSULIN RECEPTOR. JRNL REF J.MOL.BIOL. V. 315 103 2002 JRNL REFN ISSN 0022-2836 JRNL PMID 11779231 JRNL DOI 10.1006/JMBI.2001.5224 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH D.C.LIANG,W.R.CHANG,Z.L.WAN,N.M.VIJAYAN REMARK 1 TITL A PROPOSED INTERACTION MODEL OF INSULIN MOLECULES WITH ITS REMARK 1 TITL 2 RECEPTOR REMARK 1 REF BIOPHYS.CHEM. V. 50 63 1994 REMARK 1 REFN ISSN 0301-4622 REMARK 1 DOI 10.1016/0301-4622(94)85020-8 REMARK 1 REFERENCE 2 REMARK 1 AUTH Q.X.HUA,M.ZHAO,N.NARAYANA,S.H.NAKAGAWA,W.JIA,M.A.WEISS REMARK 1 TITL DIABETES-ASSOCIATED MUTATIONS IN A BETA-CELL TRANSCRIPTION REMARK 1 TITL 2 FACTOR DESTABILIZE AN ANTIPARALLEL "MINI-ZIPPER" IN A REMARK 1 TITL 3 DIMERIZATION INTERFACE REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 97 1999 2000 REMARK 1 REFN ISSN 0027-8424 REMARK 1 DOI 10.1073/PNAS.97.5.1999 REMARK 1 REFERENCE 3 REMARK 1 AUTH H.B.OLSEN,S.LUDVIGSEN,N.C.KAARSHOLM REMARK 1 TITL THE RELATIONSHIP BETWEEN INSULIN BIOACTIVITY AND STRUCTURE REMARK 1 TITL 2 IN THE NH2-TERMINAL A-CHAIN HELIX REMARK 1 REF J.MOL.BIOL. V. 284 477 1998 REMARK 1 REFN ISSN 0022-2836 REMARK 1 DOI 10.1006/JMBI.1998.2175 REMARK 1 REFERENCE 4 REMARK 1 AUTH Q.X.HUA,S.Q.HU,B.H.FRANK,W.JIA,Y.C.CHU,S.H.WANG,G.T.BURKE, REMARK 1 AUTH 2 P.G.KATSOYANNIS,M.A.WEISS REMARK 1 TITL MAPPING THE FUNCTIONAL SURFACE OF INSULIN BY DESIGN: REMARK 1 TITL 2 STRUCTURE AND FUNCTION OF NOVEL A-CHAIN ANALOGUE REMARK 1 REF J.MOL.BIOL. V. 264 390 1996 REMARK 1 REFN ISSN 0022-2836 REMARK 1 DOI 10.1006/JMBI.1996.0648 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.1 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 89.2 REMARK 3 NUMBER OF REFLECTIONS : 3160 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.241 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 300 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 803 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 2 REMARK 3 SOLVENT ATOMS : 36 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 2.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.80 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.680 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1JCA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-JUN-01. REMARK 100 THE DEPOSITION ID IS D_1000013615. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JAN-00 REMARK 200 TEMPERATURE (KELVIN) : 290 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : MIRROR REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS II REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 3169 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 10.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : 2.000 REMARK 200 R MERGE (I) : 0.07100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.59 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.5 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.16000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: PDB ENTRY 1TRZ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.43 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.03 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: TRIS, SODIUM CITRATE, ACETONE, PHENOL, REMARK 280 PH 7.0, VAPOR DIFFUSION, HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: H 3 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 X+2/3,Y+1/3,Z+1/3 REMARK 290 5555 -Y+2/3,X-Y+1/3,Z+1/3 REMARK 290 6555 -X+Y+2/3,-X+1/3,Z+1/3 REMARK 290 7555 X+1/3,Y+2/3,Z+2/3 REMARK 290 8555 -Y+1/3,X-Y+2/3,Z+2/3 REMARK 290 9555 -X+Y+1/3,-X+2/3,Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 40.32600 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 23.28223 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 12.64533 REMARK 290 SMTRY1 5 -0.500000 -0.866025 0.000000 40.32600 REMARK 290 SMTRY2 5 0.866025 -0.500000 0.000000 23.28223 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 12.64533 REMARK 290 SMTRY1 6 -0.500000 0.866025 0.000000 40.32600 REMARK 290 SMTRY2 6 -0.866025 -0.500000 0.000000 23.28223 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 12.64533 REMARK 290 SMTRY1 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 46.56445 REMARK 290 SMTRY3 7 0.000000 0.000000 1.000000 25.29067 REMARK 290 SMTRY1 8 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 8 0.866025 -0.500000 0.000000 46.56445 REMARK 290 SMTRY3 8 0.000000 0.000000 1.000000 25.29067 REMARK 290 SMTRY1 9 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 9 -0.866025 -0.500000 0.000000 46.56445 REMARK 290 SMTRY3 9 0.000000 0.000000 1.000000 25.29067 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS A HEXAMER GENERATED FROM THE REMARK 300 DIMER IN THE ASYMMETRIC UNIT BY THE OPERATIONS: -Y, X-Y, Z AND -X+Y, REMARK 300 -X, Z. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5220 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10590 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -90.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5190 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10870 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -117.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DODECAMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 17590 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14280 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -263.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 ZN ZN B 41 LIES ON A SPECIAL POSITION. REMARK 375 ZN ZN D 42 LIES ON A SPECIAL POSITION. REMARK 400 REMARK 400 COMPOUND REMARK 400 The crystallographic asymmetric unit of insulin REMARK 400 consists of two insulin monomers each consisting REMARK 400 of two heterochains. REMARK 400 The entry presents coordinates for monomer 1 REMARK 400 (chain indicators A and B) and monomer 2 (chain REMARK 400 indicators C and D). There are two zinc ions per REMARK 400 insulin hexamer located on the three-fold axis. REMARK 400 The conformations of two monomers are different REMARK 400 as the result of a change in conformation of the REMARK 400 first eight residues of the B-chain. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PHE D 1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 HIS B 5 NE2 HIS B 5 CD2 -0.068 REMARK 500 HIS B 10 NE2 HIS B 10 CD2 -0.070 REMARK 500 HIS D 5 NE2 HIS D 5 CD2 -0.069 REMARK 500 HIS D 10 NE2 HIS D 10 CD2 -0.070 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B 41 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B 10 NE2 REMARK 620 2 HIS B 10 NE2 101.9 REMARK 620 3 HIS B 10 NE2 101.9 101.9 REMARK 620 N 1 2 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN D 42 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS D 10 NE2 REMARK 620 2 HIS D 10 NE2 105.4 REMARK 620 3 HIS D 10 NE2 105.4 105.4 REMARK 620 N 1 2 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 41 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN D 42 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1J73 RELATED DB: PDB REMARK 900 1J73 CONTAINS THE SAME SEQUENCE AND STRUCTURE, BUT SUBSTITUTION OF REMARK 900 DAB-A8 RESIDUE BY LYSINE DBREF 1JCA A 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 1JCA B 1 30 UNP P01308 INS_HUMAN 25 54 DBREF 1JCA C 1 21 UNP P01308 INS_HUMAN 90 110 DBREF 1JCA D 1 30 UNP P01308 INS_HUMAN 25 54 SEQADV 1JCA LYS A 8 UNP P01308 THR 97 ENGINEERED MUTATION SEQADV 1JCA LYS C 8 UNP P01308 THR 97 ENGINEERED MUTATION SEQRES 1 A 21 GLY ILE VAL GLU GLN CYS CYS LYS SER ILE CYS SER LEU SEQRES 2 A 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 B 30 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 B 30 ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY PHE PHE TYR SEQRES 3 B 30 THR PRO LYS THR SEQRES 1 C 21 GLY ILE VAL GLU GLN CYS CYS LYS SER ILE CYS SER LEU SEQRES 2 C 21 TYR GLN LEU GLU ASN TYR CYS ASN SEQRES 1 D 30 PHE VAL ASN GLN HIS LEU CYS GLY SER HIS LEU VAL GLU SEQRES 2 D 30 ALA LEU TYR LEU VAL CYS GLY GLU ARG GLY PHE PHE TYR SEQRES 3 D 30 THR PRO LYS THR HET ZN B 41 1 HET ZN D 42 1 HETNAM ZN ZINC ION FORMUL 5 ZN 2(ZN 2+) FORMUL 7 HOH *36(H2 O) HELIX 1 1 GLY A 1 CYS A 6 1 6 HELIX 2 2 SER A 12 ASN A 18 1 7 HELIX 3 3 CYS B 7 GLY B 20 1 14 HELIX 4 4 GLU B 21 GLY B 23 5 3 HELIX 5 5 GLY C 1 CYS C 6 1 6 HELIX 6 6 SER C 12 GLU C 17 1 6 HELIX 7 7 ASN D 3 GLY D 20 1 18 HELIX 8 8 GLU D 21 GLY D 23 5 3 SHEET 1 A 2 PHE B 24 TYR B 26 0 SHEET 2 A 2 PHE D 24 TYR D 26 -1 O PHE D 24 N TYR B 26 SSBOND 1 CYS A 6 CYS A 11 1555 1555 2.01 SSBOND 2 CYS A 7 CYS B 7 1555 1555 2.02 SSBOND 3 CYS A 20 CYS B 19 1555 1555 2.02 SSBOND 4 CYS C 6 CYS C 11 1555 1555 2.02 SSBOND 5 CYS C 7 CYS D 7 1555 1555 2.02 SSBOND 6 CYS C 20 CYS D 19 1555 1555 2.02 LINK NE2 HIS B 10 ZN ZN B 41 1555 1555 2.22 LINK NE2 HIS B 10 ZN ZN B 41 2555 1555 2.22 LINK NE2 HIS B 10 ZN ZN B 41 3555 1555 2.22 LINK NE2 HIS D 10 ZN ZN D 42 1555 1555 1.93 LINK NE2 HIS D 10 ZN ZN D 42 2555 1555 1.93 LINK NE2 HIS D 10 ZN ZN D 42 3555 1555 1.93 SITE 1 AC1 1 HIS B 10 SITE 1 AC2 1 HIS D 10 CRYST1 80.652 80.652 37.936 90.00 90.00 120.00 H 3 18 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012399 0.007159 0.000000 0.00000 SCALE2 0.000000 0.014317 0.000000 0.00000 SCALE3 0.000000 0.000000 0.026360 0.00000